NEOGEN.NS(NEOGEN.NS)
NEOGEN.NS
No analyst ratings available
No analyst price targets available for NEOGEN.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $12.43B | $21.52B | $25.68B | $30.02B | $46.57B |
| Low | $11.73B | $18.70B | $22.09B | $26.58B | $41.24B |
| High | $13.41B | $23.52B | $27.39B | $32.47B | $50.38B |
| EBITDA Avg | $2.12B | $3.67B | $4.38B | $5.12B | $7.95B |
| Low | $2.00B | $3.19B | $3.77B | $4.54B | $7.04B |
| High | $2.29B | $4.01B | $4.67B | $5.54B | $8.59B |
| EBIT Avg | $1.75B | $3.03B | $3.62B | $4.23B | $6.56B |
| Low | $1.65B | $2.64B | $3.11B | $3.75B | $5.81B |
| High | $1.89B | $3.31B | $3.86B | $4.58B | $7.10B |
| Net Income Avg | $567M | $1.41B | $1.51B | $2.40B | $3.68B |
| Low | $389M | $1.01B | $804M | $2.05B | $3.13B |
| High | $909M | $1.41B | $2.90B | $2.66B | $4.07B |
| EPS Avg | $22.64 | $48.60 | $64.06 | $91.17 | $139.40 |
| Low | $14.74 | $38.26 | $30.47 | $77.60 | $118.66 |
| High | $34.46 | $53.64 | $110.11 | $100.86 | $154.22 |
| Analysts (Rev / EPS) | 9 / 9 | 9 / 6 | 4 / 4 | 3 / 2 | 2 / 3 |